[1] Zhu L, Li D, Zhang X, et al.Comparative efficacy on outcomes of C-CABG, OPCAB, and ONBEAT in coronary heart disease: a systematic review and network meta-analysis of randomized controlled trials[J]. Int J Surg,2023,109(12):4263-4272. [2] Zhang T, Yang X, Zhuang Q, et al.Study on myocardial infarction based on nationwide inpatient sample database: a bibliometric analysis from 2000 to 2022[J]. Emerg Crit Care Med,2024,4(1):22-27. [3] Mastroiacovo G, Bonomi A, Ludergnani M, et al. Is EuroSCORE Ⅱ still a reliable predictor for cardiac surgery mortality in2022? A retrospective study study[J]. Eur J Cardiothorac Surg,2022,64(3):ezad294. [4] Bedi S, Liu Y, Orr-Ewing L et al. Testing and evaluation of health care applications of large language models: a systematic review[J]. JAMA,2025,333(4):319-328. [5] Allyn J, Allou N, Augustin P et al. A comparison of a machine learning model with EuroSCORE Ⅱ in predicting mortality after elective cardiac surgery: a decision curve analysis[J]. PLoS One,2017,12(1):e0169772. [6] Hijazi E. Enhancing mortality prediction after coronary artery bypass graft: a machine learning approach utilizing EuroScore[J]. Future Sci OA,2024,10(1):FSO959. [7] Doenst T, Haverich A, Serruys P, et al.PCI and CABG for treating stable coronary artery disease: JACC review topic of the week[J]. J Am Coll Cardiol,2019,73(8):964-976. [8] Schafer A, Alasnag M, Giacoppo D, et al.High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery[J]. EuroIntervention,2025,21(1):22-34. [9] Nashef SA, Sharples LD, Roques F, et al.EuroSCORE Ⅱ and the art and science of risk modelling[J]. Eur J Cardiothorac Surg,2013,43(4):695-696. [10] Di Dedda U, Pelissero G, Agnelli B, et al.Accuracy, calibration and clinical performance of the new EuroSCORE Ⅱ risk stratification system[J]. Eur J Cardiothorac Surg,2013,43(1):27-32. [11] Neumann FJ, Sousa-Uva M, Ahlsson A, et al.2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165. [12] Di Bacco L, D'Alonzo M, Baudo M, et al. Reliability of EuroSCORE Ⅱ on prediction of thirty-day mortality and long-term results in patients treated with sutureless valves[J]. J Clin Med,2024,13(13):3986. [13] Birlik AB, Tozan H, Kose KB.Machine learning-based hybrid risk estimation system (ERES) in cardiac surgery: supplementary insights from the ASA score analysis[J]. PLoS Digit Health,2025,4(6):e0000889. [14] Fang SY, Chen JW, Chou HW, et al.Validation of the European system for cardiac operative risk evaluation Ⅱ in a large Taiwan cardiac surgical centre[J]. J Formos Med Assoc, 2023,122(12):1265-1273. [15] Arfat Y, Mittone G, Esposito R, et al.Machine learning for cardiology[J]. Minerva Cardiol Angiol,2022,70(1):75-91. [16] Handelman GS, Kok HK, Chandra RV, et al.eDoctor: machine learning and the future of medicine[J]. J Intern Med, 2018,284(6):603-619. [17] Jia T, Xu K, Bai Y, et al.Machine-learning predictions for acute kidney injuries after coronary artery bypass grafting: a real-life muticenter retrospective cohort study[J]. BMC Med Inform Decis Mak,2023,23(1):270. |